With their hands on the legal levers

It is wonderful news for the Scandinavian scientific community. At the end of May it stood clear that Lund will host to the European Spallation Source.

Personliga läkemedel öppnar för nya företag

Vi har hört om det, läst om det, hört om det igen och läst om genombrotten som ska komma, men än är vi inte riktigt där.

Academy for a new turn at work

Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.

A platform for dialogue

As a step towards connecting the life science industry in Denmark, Biologue was founded three years ago with 10 member companies. Today, the network has 40 memb...

New tools to fight bacteria

Better guidelines for doctors, detailed patient journals, and national monitoring systems are some of the tools needed to combat the increasing problem of antib...

Time to save for survival

The future is bright for the biotech industry. However, the companies need to cut costs immediately if they want to survive the rough economic times.

Early stage research and low turnaround dominates

Nordic science parks are full of advanced research performed by small companies but little research is done in later stages. Only a couple of the best performer...

International models among science parks

Science parks have become a part of modern communities. With science parks in Oxford, Cambridge and Nice setting good examples, a special potential emerged. Cou...

Big Data på internationell basis

Stora datamängder kommer revolutionera forskningen. Det tror forskarna som jobbar på att hitta ett sätt att sammanställa metoder och information på ett internationellt sätt.

Young, bright and committed to labtech

Ghazal Voghoui recently bought her first apartment and finally settled in Stockholm again. Last year, she finished her law studies and she is relieved to be bac...

A+ Science AB

Han letar efter de enkla idéerna

Pontus Ottosson, vd på Puls som i höstas sålde läkemedelsbolaget Duocort i en miljardaffär. Nu letar de nya projekt att bygga bolag av.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recogniz...

Cytel Sweden

CTC Clinical Trial Consultants AB